Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-9-11
pubmed:abstractText
The peptidic nature of the male (H-Y) antigen, a model minor histocompatibility antigen in H-2b mice, has recently been demonstrated. In this study we show that the H-Y peptide, which is recognized by PM-1, a Db-restricted cytotoxic T-lymphocyte (CTL) clone, is absent in male H-2d spleen cells but present in male H-2d spleen cells that also express a transgenic Db molecule under its endogenous promoter. This result indicates that both the H-Y and the Db gene products are essential and sufficient for production of the Db-restricted H-Y peptide. By comparing the ability of the PM-1 clone and bulk CTL generated in a secondary mixed lymphocyte culture to recognize H-Y peptidic material eluted from affinity-purified Db molecules and separated by reversed-phase high-performance liquid chromatography (HPLC), we provide evidence that there is an immunodominant H-Y epitope that is presented by the Db molecule. Furthermore, the presentation of this epitope is not affected by a mutation in the alpha 3 domain of Db (asp227 to lys227), which abrogates CD8 binding, since similar amounts of H-Y peptide were eluted from affinity-purified wild-type or mutant Db molecules. However, the generation of the H-Y epitope is dependent on the presence of beta 2-microglobulin, since it is absent in male H-2b mice that lack a functional beta 2-microglobulin gene. The implications of these findings on T-cell development are discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1081575, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-12334405, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1314886, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1347300, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1372256, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-13800711, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1454824, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1552287, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1606619, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1613468, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1634779, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1695760, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1709722, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1718764, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-1940788, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2032287, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2034289, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2109837, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2112266, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2147006, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2234092, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2462676, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2490502, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2526642, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2666863, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-2831066, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-3257986, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-3260350, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-3532114, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-3877776, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-7026417, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-7191868, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-7522161, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-7694638, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-8294864, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-8294874, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-8464897, http://linkedlifedata.com/resource/pubmed/commentcorrection/7543449-91527
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0019-2805
pubmed:author
pubmed:issnType
Print
pubmed:volume
85
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
74-81
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
A mutation in the alpha 3 domain of Db that abrogates CD8 binding does not affect presentation of an immunodominant H-Y peptide.
pubmed:affiliation
Department of Microbiology and Immunology, University of British Columbia, Vancouver, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't